Basic Research Open Access
Copyright ©The Author(s) 2002. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 15, 2002; 8(1): 188-192
Published online Feb 15, 2002. doi: 10.3748/wjg.v8.i1.188
Study on the mechanism of regulation on peritoneal lymphatic stomata with Chinese herbal medicine
Shi-Ping Ding, Ji-Cheng Li, Lian-Gen Mao, Department of Lymphology, Department of Histology and Embryology, Medical College of Zhejiang University, School of Medicine, Hangzhou 310031, China
Jian Xu, Hangzhou First People’s Hospital, Hangzhou 310001, China
Author contributions: All authors contributed equally to the work.
Supported by the National Natural Science Foundation of China,No. 39970934, Scientific Research Fund by the Science Technology Committee of Hangzhou, State Administration of Traditional Chinese Medicine, No.927031, Zhejiang Provincial Administration of Traditional Chinese Medicine, fund for outstanding talents by the Chinese Ministry of Health and Analysis and Testing Fund of Zhejiang Province, No.00159
Correspondence to: Dr. Ji-Cheng Li, Department of Lymphology, Department of Histology and Embryology, Zhejiang University, School of Medicine,Hangzhou 310031, China. lijc@mail.hz.zj.cn
Telephone: +86-571-87217139 Fax: +86-571-87217139
Received: August 23, 2001
Revised: October 19, 2001
Accepted: November 5, 2001
Published online: February 15, 2002

Abstract

AIM: To study the mechanism of Chinese herbal medicine (CHM, the prescription consists of Radix Salviae Miltiorrhizae, Radix Codonopsitis Pilosulae, Rhizoma Atractylodis Alba and Rhizoma Alismatis, Leonurus Heterophyllus Sweet, etc) on the regulation of the peritoneal lymphatic stomata and the ascites drainage.

METHODS: The mouse model of live fibrosis was established with the application of intragastric installations of carbon tetrachloride once every three days; scanning electron microscope and computer image processing were used to detect the area and the distributive density of the peritoneal lymphatic stomata; and the concentrations of urinary ion and NO in the serum were analyzed in the experiment.

RESULTS: Two different doses of CHM could significantly increase the area of the peritoneal lymphatic stomata, promote its distributive density and enhance the drainage of urinary ion such as sodium, potassium and chlorine. Meanwhile, the NO concentration of two different doses of CHM groups was 133.52 ± 23.57 μmol/L, and 137.2 ± 26.79 μmol/L respectively. In comparison with the control group and model groups (48.36 ± 6.83 μmol/L, and 35.22 ± 8.94 μmol/L, P < 0.01), there existed significantly marked difference, this made it clear that Chinese herbal medicine could induce high endogenous NO concentration. The effect of Chinese herbal medicine on the peritoneal lymphatic stomata and the drainage of urinary ion was altered by adding NO donor(sodium nitropurruside, SNP) or NO synthase (NOS) inhibitor (N(G)-monomethyl-L-arginine, L-NMMA) to the peritoneal cavity.

CONCLUSION: There existed correlations between high NO concentration and enlargement of the peritoneal lymphatic stomata, which result in enhanced drainage of ascites. These data supported the hypothesis that Chinese herbal medicine could regulate the peritoneal lymphatic stomata by accelerating the synthesis and release of endogenous NO.




INTRODUCTION

Numerous investigatious have demonstrated that the peritoneal lymphatic stomata are small openings of the subperitoneal lymphatic vessels both in animals and in humans[1-18]. It has also been observed that particles, cells and solutions containing vital dyes are absorbed rapidly by the peritoneal lymphatic stomata[19-22]. Subsequent researches suggested that the peritoneal cavity is an integral part of the lymphatic system with enormous absorption powers, functioning primarily by means of the subperitoneal lymphatics via the peritoneal lymphatic stomata[23-29]. Thus, it has important clinical implications, especially in ascites drainage[30-32]. In recent years, therapeutic effect of Chinese herbal medicine (CHM) on the ascites has also drawn world wide attention among he scholars. It is further confirmed that Chinese herbal medicine can regulate the lymphatic stomata and promote the excretion of substance from the peritoneal cavity, which showed a good future in the treatment of the hepatocirrhosis with ascites[33-44]. However, it is still unclear how the lymphatic stomata is regulated by the Chinese herbal medicineThis article aimed at the regulation of CHM on the lymphatic stomata in the mouse liver fibrosis model induced by CCl4, which provided theoretical evidence on ascites. Furthermore, by the application of NO donor (SNP) and NOS inhibitor (L-NMMA), the effect of NO was studied on the peritoneal lymphatic stomata in order to clarify the mechanism of CHM on the regulation of the peritoneal lymphatic stomata.

MATERIAL AND METHODS
Experimental CHM

By examining a computerized media index, the conventional remedies of CHM was selected for the treatment of hepatocirrhosis with ascites. The Chinese composite prescription was supplied by Zhejiang Academy of Traditional Chinese Medicine. The prescription consisted of Radix Salviae Miltiorrhizae, Radix Codonopsitis Pilosulae, Rhizoma Atractylodis Alba and Rhizoma Alismatis, Leonurus Heterophyllus Sweet. The medicament was immersed in the 750 mL·L-1 alcohol for 24 h, then purified with rotatory evaporator (ZFQ85A type, produced by Shanghai 11th Factory of Electron Tube). The crude drug content was 15.2 g·mL-1.

Animal and grouping

Ninety healthy mature NIH male mice, weighing 25 g-30 g, provided by the Experimental Animal Center of Zhejiang Academy of Medical Sciences, were selected and divided at random into six groups (each of 15 mice): the control group (NS group), model group, low dose of CHM group (CHMI), high dose of CHM group (CHMII), the donor group (DR group) and the inhibitor group (IR group).

Mouse liver fibrosis model

Except the NS group, the other experimental mice were fed freely with 50 mL·L-1 alcohol solution instead of water for 1 week, then the mice were given 100 mL·L-1 CCl4 rape-seed oil solution 0.1 mL/10g by gastrogavage every 3 days for 6 weeks to induce liver fibrosis. After liver fibrosis was confirmed by pathological examination, low dose of the Chinese herbal medicine (0.1 mL/10 g/day) was given to CHMIgroup, high dose of the Chinese herbal medicine (0.2 mL/10 g/day) was give to CHMII group, normal saline (0.2 mL/10 g/day) was given to DR group, for 3 weeks respectively. After the 10 th week, DR and IR group was additionally injected intraperitoneally with 50 μg/10 g/day NO donor (SNP) or 80 μg/10 g/day NOS inhibitor (L-NMMA) for two days respectively. Model group was untreated and NS group was given 0.2 mL/10 g of normal saline per day.

Preparation of samples for scanning electron microscopic examination and computer image processing

The diaphragmatic peritoneum on the right side was cut into 5.0 × 5.0 mm2 pieces and put into 25 mL·L-1 glutaraldehyde solution for 1 h, then postfixed for 1 h in 10 mL·L-1 OsO4, dehydrated in a graded series of alcohol, CO2 critical-point dried, mounted on aluminum tubs and sputter-coated with gold. Specimens were examined with a Stereoscan 260 SEM operated at 25 kV. The result was treated with the computer image processing system attached to SEM. The system consists of video, A/D, IBM386. Software was designed for processing and quantitatively analyzing the area and the distributive density of the lymphatic stomata.

Urinary volume and ionic concentration analysis

Mouse urine was collected in 2 h and ionic concentration of Na+, K+ and Cl- was measured using auto-biochemical analyzer (Beckman CX △7 type).

Measurement of serum NO

Five hundred microliters of the serum was de-proteinized with 200 mL of 75 mM zinc sulfate and 250 mL of 55 mM sodium hydroxid and subsequently were centrifuged at 3000 rpm for 10min. One hundred microliters of the deproteinized solution was mixed with 0.3 mL ddH2O and 0.25 g newly-activated Cadmium sufficiently for 1 h. The nitrite concentration was determined by mixing 0.1 mL of the supernatants from the mixed solution with an equal volume of Griess reagent (1 part of 0.2% N-(1-naphthyl) ethylenediamine dihydrochloride to 1 part of 1% sulfanilamide in 2% phosphoric acid ) for 15 min. The absorbance at 545 nm was measured, and the nitrite concentration was determined from a standard curve calibrated with NaNO2 solution[45].

Statistic analysis

The experimental results were described by -x±s and the difference among the groups was analyzed by t test.

RESULTS
Changes of peritoneal lymphatic stomata

In SEM, there were cuboidal and flattened cells in the mesothelium. The lymphatic stomata which was round or ellipse were located only among the cuboidal cells and most of them were distributed in cluster. In NS group and model groups, there were few and small lymphatic stomata (Figures 1 and 2). In contrast, there were was many and large lymphatic stomata in CHMI and CHMIIgroups (Figures 3 and 4). In DR group, there were fewer and larger lymphatic stomata than in the model group (Figure 5), while in the IR group fewer and smaller than that of the CHMII group (Figure 6).

Figure 1
Figure 1 SEM observation of mouse diaphragmatic peritoneum in the control group. Both the area and distribution density of the peritoneal lymphatic stomata (arrow) are small. × 3500
Figure 2
Figure 2 SEM observation of mouse diaphragmatic peritoneum in model group showing the peritoneal stomata (arrow). × 3500
Figure 3
Figure 3 SEM observation of mouse diaphragmatic peritoneum in CHMI group. The area and distribution density of the peritoneal lymphatic stomata (arrow) are significantly increased. × 3500
Figure 4
Figure 4 SEM observation of mouse diaphragmatic peritoneum in CHMII group. The area and distribution density of the peritoneal lymphatic stomata (arrow) are significantly increased. × 3500
Figure 5
Figure 5 SEM observation of mouse diaphragmatic peritoneum in DR group. Compared with model group, the area and distribution density of the peritoneal lymphatic stomata (arrow) are relatively increased. × 3500
Figure 6
Figure 6 SEM observation of mouse diaphragmatic peritoneum in IR group. Compared with CHMII group, the area and distribution density of the peritoneal lymphatic stomata (arrow) are relatively decreased. × 3500

With image processing, the average area of the stomata was 3.59 ± 1.29 μm2 in NS group and 3.02 ± 1.11 μm2 in model group, whereas in CHMI group and CHMII group, the average area of the stomata was 5.89 ± 0.33 μm2, and 5.93 ± 1.87 μm2 respectively. There were significant differences in the enlargement of the stomata between CHMI and CHMII groups, based on the analysis of variance (P < 0.01). By comparing the area at the 99% confidence interval of population means, we found that the stomata area of CHMI and CHMII groups were much larger than those of NS and model groups (Table 1).

Table 1 The influence of CHM, NO donor and NOS inhibitor (n = 15) on the area of the lymphatic stomata.
GroupsMean (μm2)SDMin.(μm2)Max.(μm2)
NS3.591.290.918.93
model group3.021.111.837.53
CHMIbd5.890.332.009.82
CHMIIbd5.931.872.0810.15
DRc4.370.101.928.70
IRf2.701.301.759.19

When the mouse was injected intraperitoneally by SNP, the average area of the stomata was 4.37 ± 0.10 ìm2, which was larger than that of the corresponding model group. When the mouse was injected intraperitoneally by L-NMMA, the average area of the stomata was 2.70 ± 1.30 μm2, which was smaller than that of the corresponding CHMII group. These showed that the area of the stomata could be altered by SNP or L-NMMA significantly (P < 0.05 or P < 0.01).

The average distribution density of the stomata of NS group, and model group were 66.99 ± 5.43/0.01 mm2, 42.80 ± 13.35/0.01 mm2, whereas those of CHMI and CHMII group were 92.08 ± 0.44/0.01 mm2, and 96.24 ± 4.62/0.01 mm2 respectively. The results showed that CHM can promote the distribution density of the stomata significantly (Figure 7) (P < 0.01).

Figure 7
Figure 7 The influence of CHM, NO donor and NOS inhibitor on the distribution density of the lymphatic stomata.

When the mouse was injected intraperitoneally by SNP, the average distribution density of the stomata was 79.06 ± 5.37 mm2/0.01 mm2, which was much migher than that of the corresponding model group. When the mouse was injected intraperitoneally by L-NMMA, the average distribution density of the stomata was 60.82 ± 30.79 mm2/0.01 mm2, which was much lower than that of the corresponding CHM group. The above statistics show that the distribution density of the stomata could be altered by SNP or L- NMMA significantly (P < 0.01).

Comparison of urinary ionic concentration

Subsequent experiment showed that the excretion of Na+, K+ and Cl- in CHMI and CHMII group was significantly higher than those in NS group and model groups respectively (P < 0.01) (Table 2).

Table 2 The effect of CHM, NO donor, NOS inhibitor on the urinary ion of the mice (mmol/L, n = 15).
GroupsNa+K+Cl-
NS91.55 ± 23.42106.15 ± 34.16111.18 ± 30.05
model group97.48 ± 42.12129.65 ± 46.91121.90 ± 41.65
CHMI202.09 ± 35.30bd217.30 ± 57.78bd176.00 ± 0.00bc
CHMII170.78 ± 17.05bd210.11 ± 51.49bd184.72 ± 13.81bd
DR126.74 ± 51.27d142.16 ± 6.33c134.18 ± 30.36c
IR139.28 ± 26.02f88.29 ± 22.59f154.98 ± 14.88e

When NO donor was injected intraperitoneally, the excretion of Na+, K+ and Cl- in DR group was significantly higher than those in the model group (P < 0.05 or P < 0.01). When NO inhibitor was injected intraperitoneally, the excretion of Na+, K+ and Cl-in IR group decreased significantly in comparison with the corresponding CHMII group (P < 0.05 or P < 0.01).

Comparison of NO concentration

There were significant difference in the concentration of NO between groups. The NO concentration of NS, model groups was 48.36 ± 6.83 μmol/L and 35.22 ± 8.94 μmol/L respectively, however that of CHMI and CHMII group was 133.52 ± 23.57 μmol/L and 137.2 ± 26.79 μmol/L. The results showed that the concentration of NO in CHMI and CHMII groups was higher than that in NS and model groups (P < 0.01) (Figure 8). The results indicated that Chinese herbal medicine could induce higher endogenous NO. When NO donor was injected intraperitoneally, NO concentration in DR group was 62.56 ± 18.91 μmol/L, which was significantly higher than that in the model group (P < 0.05). When NO inhibitor was injected intraperitoneally, NO concentration in IR group was 99.88 ± 21.03 μmol/L, which decreased significantly as compared with that of CHMII group (P < 0.01).

Figure 8
Figure 8 The change of NO concentration by using CHM,NO donor and NOS inhibitor in the mice.
DISCUSSION

In the mesothelial cells constituting the lymphatic stomata, there exists bundles of actin microfilaments, the contraction and relaxation of the microfilaments could result in the change of the diameter of the lymphatic stomata. Because the lymphatic stomata is the main pathway of the drainage of the material from the peritoneal cavity[23-29], further investigation on regulating mechanism of the lymphatic stomata could promote the treatment of ascites and other associated illness.

With regard to the regulation of patency of the stomata, some authors have proposed that the peritoneal lymphatic stomata open passively when the diaphragm stretches during expiration, and close passively when it contracts during inspiration. Tsilibary and Wissig observed the regulation of the stomata by means of intravenously injecting carbacholine and succinylcholine, which cause the contraction and relaxation of the mouse diaphragm[3]. Their experimental results showed that stomata opened and closed with drug-induced relaxation and contraction of the diaphragm. Changes of the intra-abdominal pressure also play an important role on the regulation of the peritoneal lymphatic stomata. When the intra-abdominal pressure is increased experimentally by injecting normal saline intraperitoneally, the amount of the peritoneal lymphatic stomata is much larger than that of the normal group.On the contrary, when the intra-abdominal pressure is decreased experimentally, the patent number of the peritoneal lymphatic stomata is much less than that of the normal group[3].

Li et al[37-39] and Lv et al[40-44] further confirmed the effect of some Chinese herbal medicine such as Radix Salviae Miltiorrhizae, Radix Codonopsitis Pilosulae, Rhizoma Atractylodis Alba and Rhizoma Alismatis in the regulation of the peritoneal lymphatic stomata significantly by increasing the average diameter and the average distribution densities respectively, which can enhance fluid drainage into the vascular system.This is of important clinical significance in treating ascites caused by liver cirrhosis. In the present study, the prescription is made up according to the traditional Chinese medicinal therapeutic principle in treating “hypocondriac pain”, “lump” and “tympanites”. The drug has the effects of activating blood circulation to remove stasis, strengthening Spleen, supplementing Qi, and smoothening Qi to eliminate fullness. Our study showed that the CHM in the experiment could regulate the peritoneal lymphatic stomata significantly by increasing the average area and the average distribution densities respectively. Meanwhile, the medicines could enhance the drainage of urinary ion such as sodium, potassium and chlorine. The finding has further confirmed Li et al’s results[37-39] and Lv et al’s results[40-44].

It can also be seen that both dosage of CHM could induce higher concentration of NO, that is, the high endogenous NO production is associated with the enlargement of the peritoneal lymphatic stomata and the increase of the drainage of urinary ion. Further results indicated that great changes could occur in the area and the distribution density of the lymphatic stomata when the NO donor or NOS inhibitor was injected intraperitoneally. When NO donor was injected intraperitoneally,i.e., the concentration of the endogenous NO increased, the area and the distribution density of the lymphatic stomata in the NO donor group were much larger than those of the model group (P < 0.05 or P < 0.01). Moreover, when NO inhibitor was given, the concentration of the endogenous NO decreased, these indexes of the lymphatic stomata in NO inhibitor group were much less than those of the corresponding large dose of CHM (P < 0.01). Thus, it could be seen that the effect of CHM on the peritoneal lymphatic stomata was altered by adding NO donor or NOS inhibitor to the peritoneal cavity.

It has confirmed that the endothelium-derived relaxing factor (EDRF) is nitric oxide[46-49], which has an effect in relaxing the blood vessel. Li et al reported that, with the proceeding of the peritoneal dialysis.Clinically, numerous macrophages were found to enter the peritoneal cavity to form milky spots. Damages of mesothelial cells, increased density of their distribution and enlargement of the peritoneal lymphatic stomata were found to be associated with the increase of macrophage NO quantity. Furthermore, increased NO production was related to the enlargement of the peritoneal lymphatic stomata in the long-term peritoneal dialysis. Therefore, Li et al[50] proposed that NO could relax the lymphatic stomata which lead to the enhanced lymph absorption or ultrafiltration failure. On these grounds, we suggested that the regulation of CHM on the lymphatic stomata may be related to endogenous NO.Chinese herbal medicine may regulate the lymphatic stomata by accelerating the synthesis and release of endogenous NO. Nitric oxide as an endothelium-derived relaxing factor,mediates its biological effects by activating soluble guanylyl cyclase and increasing cyclic GMP synthesis from GTP and decreasing the concentration of Ca2+. These reactions result in the strong relaxation of the lymphatic stomata, with the area and the distribution densities of the lymphatic stomata enlarged, which would lead to the drainage of ascites from the peritoneal cavity.

Footnotes

Edited by Ma JY

References
1.  Leak LV, Rahil K. Permeability of the diaphragmatic mesothelium: the ultrastructural basis for "stomata". Am J Anat. 1978;151:557-593.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 115]  [Cited by in F6Publishing: 118]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
2.  Tsilibary EC, Wissig SL. Absorption from the peritoneal cavity: SEM study of the mesothelium covering the peritoneal surface of the muscular portion of the diaphragm. Am J Anat. 1977;149:127-133.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 90]  [Cited by in F6Publishing: 96]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
3.  Tsilibary EC, Wissig SL. Lymphatic absorption from the peritoneal cavity: regulation of patency of mesothelial stomata. Microvasc Res. 1983;25:22-39.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 93]  [Cited by in F6Publishing: 73]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
4.  Tsilibary EC, Wissig SL. Light and electron microscope observations of the lymphatic drainage units of the peritoneal cavity of rodents. Am J Anat. 1987;180:195-207.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 55]  [Cited by in F6Publishing: 56]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
5.  Li JC, Yu SM. Ultrastructural study on the peritoneal stomata in human fetuses. Jiepou Xuebao. 1990;21:359-361.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Li JC, Yu SM. Study on the ultrastructure of the peritoneal stomata in humans. Acta Anat (Basel). 1991;141:26-30.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 39]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
7.  Li J. [Electron microscopic study of mesothelial cells in the diaphragm peritoneum of human fetus using the freeze-fracture replica method]. Zhongguo Yixue Kexueyuan Xuebao. 1991;13:189-194.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Li JC. A scanning electron microscopic study on capillary configuration of human diaphragmatic peritoneum. Keji Tongbao. 1992;8:57-61.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Li JC, Chen XB. Study of the human peritoneal stomata and its clinical significance. Zhonghua Shiyan Waike Zazhi. 1992;9:38-39.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Li J, Gao Y, Yong T. [Study on the pelvic stomata and computer image processing]. Zhongguo Yixue Kexueyuan Xuebao. 1994;16:264-269.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Li JC, Gao YS. The study of quantative image processing on the ultrastructure of the pelvic stomata in humans. XVIIIth meeting of the European group of lymphology, Belgium, Brussels, 1994: Abstracts. .  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Li JC, Zhao ZR, Gao YS, Zhou JL. Study on human pelvic stomata by using the self-made SEM image processing system. Zhonghua Wuli Yixue Zazhi. 1995;17:104-106.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Li J, Zhou J, Gao Y. The ultrastructure and computer imaging of the lymphatic stomata in the human pelvic peritoneum. Ann Anat. 1997;179:215-220.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 16]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
14.  Li JC, Lv ZL, Shi YH, Shen Y, Yu SM. Experimental study on the peritoneal stomata. Zhongguo Zhongyi Jichu Yixue Zazhi. 1998;4:20.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Gao YS, Li JC, Xu LS, Qian BQ. A SEM image processing system and its application in peritoneal stomata study. Shengwu Yixue Gongchengxue Zazhi. 1993;10:239-243.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Azzali G. The lymphatic vessels and the so-called "lymphatic stomata" of the diaphragm: a morphologic ultrastructural and three-dimensional study. Microvasc Res. 1999;57:30-43.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 37]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
17.  Fukuo Y, Shinohara H, Matsuda T. The distribution of lymphatic stomata in the diaphragm of the golden hamster. J Anat. 1990;169:13-21.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Negrini D, Mukenge S, Del Fabbro M, Gonano C, Miserocchi G. Distribution of diaphragmatic lymphatic stomata. J Appl Physiol (1985). 1991;70:1544-1549.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Bettendorf U. Lymph flow mechanism of the subperitoneal diaphragmatic lymphatics. Lymphology. 1978;11:111-116.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Mahedero G, Morán JM, Salas J, Blanco M. Absorption of Intralipid and interferences from nutrients infused into the peritoneal cavity of the rat. Am J Surg. 1992;164:45-50.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 21]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
21.  Marco AJ, Domingo M, Ruberte J, Carretero A, Briones V, Dominguez L. Lymphatic drainage of Listeria monocytogenes and Indian ink inoculated in the peritoneal cavity of the mouse. Lab Anim. 1992;26:200-205.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 40]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
22.  Negrini D, Del Fabbro M, Gonano C, Mukenge S, Miserocchi G. Distribution of diaphragmatic lymphatic lacunae. J Appl Physiol (1985). 1992;72:1166-1172.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Li JC, Shi YH, Chen XB, Yu SM. Study on the peritoneal stomata and absorptive mechanism of ascites. Zhongguo Yixue Kexueyuan Xuebao. 1992;14:328-333.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Li J, Jiang B. A scanning electron microscopic study on three-dimensional organization of human diaphragmatic lymphatics. Funct Dev Morphol. 1993;3:129-132.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Li JC, Jiang BY. Studies on three-dimensional configuration of dia-phragmatic lymphatics and absorptive mechanism of lymph from the peritoneal cavity. Zhongguo Yixue Kexueyuan Xuebao. 1994;16:183-187.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Li JC, Chen XB, Zhang CW, Zhou LJ, Yu SM. Ultrastructural study on human lymphatic drainage units in peritoneal stomata of human. Jiepou Xuebao. 1995;26:101-104.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Li JC, Shen Y, Gao YS, Yong TW. Quantitative study of a SEM image processing system on the absorptive mesothelium of the diaphrag-matic peritoneum. Zhongguo Yixue Kexueyuan Xuebao. 1995;17:264-268.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Li J, Zhao Z, Zhou J, Yu S. A study of the three-dimensional organization of the human diaphragmatic lymphatic lacunae and lymphatic drainage units. Ann Anat. 1996;178:537-544.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 27]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
29.  Li J, Chen X, Yu S. The ultrastructure of vesicle-containing cells and ER-cells of human peritoneum. Ann Anat. 1996;178:365-367.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 8]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
30.  Khoroshaev VA, Vorozheĭkin VM, Baĭbekov IM. [Routes of resorption of peritoneal fluid in the diaphragm in liver cirrhosis (morphologic study)]. Arkh Patol. 1991;53:40-44.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Hasbargen JA, Hasbargen BJ, Fortenbery EJ. Effect of intraperitoneal neostigmine on peritoneal transport characteristics in CAPD. Kidney Int. 1992;42:1398-1400.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 12]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
32.  Li JC, Yu SM. Study on the relation between the peritoneal stomata and net ultrafiltration in CAPD. Zhonghua Shenzangbing Zazhi. 1994;10:49-52.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Zhang B, Wang LT. The cytological mechanism of Chinese herbal medicines in antagonizing liver fibrosis. Zhongxiyi Jiehe Ganbing Zazhi. 1997;7:249-252.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Li J, Li YH, Xue LC, Wu CZ. Protective effect of Tanshinine on experimental damage of heaptocytes. Zhongxiyi Jiehe Ganbing Zazhi. 1996;6:29-30.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Aiza I, Perez GO, Schiff ER. Management of ascites in patients with chromic liver disease.. Am J Gastroenterol. 1994;1994-1996.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Zhao JP, Yuan SH, Li JC, Liu JD. Advances in the treatment of cirrhosis. Yixue Zongshu. 1999;5:477-479.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Li J, Lu Z, Wu N, Zhou J, Shi Y. A scanning electron microscopy and computer image processing morphometric study of the pharmacological regulation of patency of the peritoneal stomata. Ann Anat. 1996;178:443-447.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 10]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
38.  Li J, Lu Z, Shi Y, Shen Y, Chen Y. [Study on pharmacological regulation of the peritoneal stomata and its computer image processing]. Zhongguo Yixue Kexueyuan Xuebao. 1996;18:219-223.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Li JC, Ding WY, Shen Y, Shi YH, Zhong HL, Yu SM, Lv ZL. The influence of Chinese herbal medicines on the peritoneal lymphatic stomata in the mice. Zhongguo Bingli Shengli Zazhi. 1999;15:414.  [PubMed]  [DOI]  [Cited in This Article: ]
40.  Lv ZL, Li JC. The influence of Chinese herbal medicines for diuresis on the peritoneal stomata in mice. Zhongxiyi Jiehe Ganbing Zazhi. 1996;6:31-32.  [PubMed]  [DOI]  [Cited in This Article: ]
41.  Lv ZL, Li JC, Shi YH, Chen HM. The mechanism of Jianpi-yiqi Chinese herbal medicine treating the cirrhosis. Zhongyao Yaoli Yu Linchuang. 1996;11-12.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Lv ZL, Li JC. The mechanism of Chinese herbal medicine for blood circulation to eliminate turbid in curing ascites: observation on the regulation of red sage root on the peritoneal lymphatic stomata. Shiyong Zhongxiyi Jiehe Zazhi. 1996;9:1147-1148.  [PubMed]  [DOI]  [Cited in This Article: ]
43.  Lv ZL, Li JC, Shi YH, Chen HM. Experimental observation on the regulation of Chinese herbal medicine on the peritoneal lymphatic stomata. Zhongyi Zazhi. 1996;37:560-561.  [PubMed]  [DOI]  [Cited in This Article: ]
44.  Lv ZL, Li JC. Experimental study on the regulation of Chinese herbal medicine for diuresis to dispel tympanites on the peritoneal lym-phatic stomata of the mouse. Zhongguo Zhongxiyi Jiehe Zazhi. 1997;17:199-200.  [PubMed]  [DOI]  [Cited in This Article: ]
45.  Mao HM. Determination of nitrate in serum by a copper-coated cad-mium reduction method. Linchuang Jianyan Zazhi. 1995;13:6-8.  [PubMed]  [DOI]  [Cited in This Article: ]
46.  Murad F. Discovery of some of the biological effects of nitric oxide and its role in cell signaling (Nobel Lecture) Angew Chem Int Ed 1999; 38: 1856-1868. .  [PubMed]  [DOI]  [Cited in This Article: ]
47.  Jun Y, Fei G, Ebert MP, Malfertheiner P. Expression of inducible nitric oxide synthase in human gastric cancer. World J Gastroenterol. 1999;5:430-431.  [PubMed]  [DOI]  [Cited in This Article: ]
48.  Huang YQ, Xiao SD, Zhang DZ, Mo JZ. Nitric oxide synthase distribution in esophageal mucosa and hemodynamic changes in rats with cirrhosis. World J Gastroenterol. 1999;5:213-216.  [PubMed]  [DOI]  [Cited in This Article: ]
49.  Peng X, Feng JB, Wang SL. Distribution of nitric oxide synthase in stomach wall in rats. World J Gastroenterol. 1999;5:92.  [PubMed]  [DOI]  [Cited in This Article: ]
50.  Li JC, Zhang K, Yang ZR. Effects of peritoneal dialysis on macrophage nitric oxide production and its relation with peritoneal lymphatic stomata. Shenzangbing Yu Touxishen Yizhi Zazhi. 2000;9:13-17.  [PubMed]  [DOI]  [Cited in This Article: ]